Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy

See Locations Near You

Summary

This is a diagnostic accuracy study to evaluate if two novel ultrasound (US) techniques, quantitative 3D subharmonic imaging (SHI) and Subharmonic Aided Pressure Estimation (SHAPE), used with an intravenous ultrasound contrast agent (Definity, Lantheus Medical Imaging, Billerica, MA), can track changes in locally advanced breast cancer (LABC) angiogenesis and interstitial fluid pressure (IFP), respectively, by studying women undergoing neoadjuvant chemotherapy before as well as with around 10% and 60% (in part 1) or 30% (in part 2) of the neoadjuvant chemotherapy treatment delivered and after completion of the neoadjuvant chemotherapy treatment. Results will be compared to MRI and pathology.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Females
Be diagnosed with T1 or greater LABC, any N and M0.
Be scheduled for neoadjuvant chemotherapy
Be at least 21 years of age.
Be medically stable.
If a female of child-bearing potential, must have a negative pregnancy test.
Have signed Informed Consent to participate in the study.

Exclusion Criteria:

Males
Females who are pregnant or nursing.
Patients with other primary cancers requiring systemic treatment.
Patients with any metastatic disease.
Patients undergoing neoadjuvant endocrine therapy.
Patients with known hypersensitivity or allergy to any component of Definity.
Patients with cardiac shunts or congenital heart defects.
Patients with unstable cardiopulmonary conditions or respiratory distress syndrome.
Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension or a history of pulmonary emboli.
Patients who have received any contrast medium (X-ray, MRI, CT or US) in the 24 hours prior to the research US exam.

Study is for people with:

Breast Cancer

Estimated Enrollment:

17

Study ID:

NCT02115607

Recruitment Status:

Completed

Sponsor:

Sidney Kimmel Cancer Center at Thomas Jefferson University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

17

Study ID:

NCT02115607

Recruitment Status:

Completed

Sponsor:


Sidney Kimmel Cancer Center at Thomas Jefferson University

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider